Filings buzz in pharmaceuticals: 22% decrease in robotics mentions in Q1 of 2022
We've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
By
Filings
Latest in
Filings
Filings buzz in pharmaceuticals: 52% increase in artificial intelligence mentions in Q4 of 2021
We've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
By
Filings buzz in pharma: 68% increase in digitalization mentions in Q1 of 2022
We've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
By
Filings buzz in pharmaceuticals: 52% increase in artificial intelligence mentions in Q4 of 2021
We've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
By
Filings buzz in pharmaceuticals: 36% decrease in the future of work mentions in Q4 of 2021
We've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
By
Filings buzz in pharmaceuticals: 47% increase in big data mentions in Q4 of 2021
We've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
By
Filings buzz in pharmaceuticals: 25% decrease in industrial automation mentions in Q4 of 2021
We've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
By
Takeda announces 11.6% reported revenue growth in FY2021
For the fiscal year, the operating cash flow witnessed a 11.1% rise to $8.63bn (JPY1,123.1bn).